SCHEMBL23519069

SCHEMBL23519069

O=C(O)C(F)(F)Oc1ccc(S(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 2/20 0.47
▸ HTR6 P50406 2/20 0.47
▸ PTPN1 P18031 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ ABCC9 O60706 1/20 0.44
▸ ABCC8 Q09428 1/20 0.44
▸ KCNJ11 Q14654 1/20 0.44
▸ KCNJ8 Q15842 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ ELANE P08246 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ PKM P14618 2/20 0.43
▸ POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23519076 0.89 ELANE (0.54) HSD11B1PTPN1ALDH1A1MEN1KMT2A
SCHEMBL10983944 0.82 HTR6 (0.54) HSD11B1HTR6MEN1KMT2AABCC9
SCHEMBL17674534 0.82 SSTR4 (0.43) PTPN1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL22374794 0.81 CA2 (0.57) ALDH1A1CYP2C19HTTCA12CA1
SCHEMBL23519059 0.81 PTGS2 (0.47) PTPN1CA12CA1CA2CA9
SCHEMBL23519068 0.79 CA12 (0.39) HSD11B1PTPN1MEN1KMT2ACYP1A2
SCHEMBL23519060 0.78 HTR6 (0.54) HSD11B1HTR6MEN1KMT2AABCC9
SCHEMBL23519065 0.76 EPHX2 (0.55) KMT2APOLBMAPT
SCHEMBL24497333 0.76 ELANE (0.53) ALDH1A1ELANEPPARA
SCHEMBL23075718 0.75 HTR6 (0.54) HSD11B1HTR6ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127225-A1 ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-04-28 — — US disclosed
US-20210179554-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210179554-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SLC6A5, LIFR, SLC6A9 HSD11B1 478/4885HTR6 4585/4885PTPN1 3596/4885
US-20220127225-A1 ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS CACNA1F, SLC6A5, IDUA HSD11B1 903/4885HTR6 4750/4885PTPN1 2652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback